Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin for Vaso-occlusive Pain in Sickle Cell Disease
NCT01702246Phase 2Completed
- Sponsor
- UCSF Benioff Children's Hospital Oakland
- Start
- Feb 2012
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of simvastatin in sickle cell disease (SCD), sponsored by UCSF Benioff Children's Hospital Oakland. Primary endpoint: Change in Frequency of Vaso-occlusive Pain Events at 3 months. Started Feb 2012; status: completed.
02
Drugs
simvastatin
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT01702246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01702246.